Avidity Partners Management LP Cure Vac N.V. Transaction History

Avidity Partners Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.5 - $10.77 $7.7 Million - $12.8 Million	-1,183,900 Reduced 27.53%	3,116,100 $21.3 Million
Q2 2023 Aug 14, 2023	BUY	$6.69 - $12.25 $5.02 Million - $9.19 Million	750,000 Added 21.13%	4,300,000 $44.8 Million
Q1 2023 May 15, 2023	BUY	$6.38 - $12.5 $22.6 Million - $44.4 Million	3,550,000 New	3,550,000 $24.7 Million

12.2M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $716M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.